A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1B

Trial Identifier:	LTS13619
Sponsor:	Sanofi
Start Date:	September 2013
Primary Completion Date:	June 2031
Study Completion Date:	June 2031
Condition:	Usher Syndrome

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
France	Paris, France, 75012
UNITED STATES, Oregon	Portland, Oregon, UNITED STATES, 97239-3098

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.